| Financial Year |
March 31 2023 |
| Monetary Funds |
397,499,924.29 |
| Held-for-trading Financial Assets |
358,565,604.54 |
| Notes Receivable |
14,023,449.67 |
| Accounts Receivable |
459,488,771.79 |
| Advances to Suppliers |
12,010,076.44 |
| Other Receivables |
5,169,402.14 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
372,643,188.80 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
42,563,998.52 |
| Total Current Assets |
1,673,450,472.36 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
1,129,913,220.52 |
| Under-construction Projects |
95,352,973.20 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
136,533,645.52 |
| R&D expenses |
-- |
| Goodwill |
34,008,972.97 |
| Long-Term Deferred and Prepaid Expenses |
30,507,852.34 |
| Deferred Income Tax Assets |
85,509,406.80 |
| Other Non-Current Assets |
25,258,432.31 |
| Sub-Total of Non-Current Assets |
1,598,956,109.67 |
| Total Assets |
3,272,406,582.03 |
| Short-Term Loans |
350,925,637.13 |
| Trading Financial liabilities |
-- |
| Notes Payable |
375,909,215.22 |
| Accounts Payable |
333,474,396.26 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
77,238,011.88 |
| Taxes Payable |
3,560,053.34 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
82,518,094.55 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
10,778,068.92 |
| Other Current Liabilities |
2,341,765.52 |
| Sub-Total of Current Liabilities |
1,264,989,681.32 |
| Long-term Loans |
53,344,531.62 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
22,302,293.84 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
159,650,512.12 |
| Total Liabilities |
1,424,640,193.44 |
| Paid-In Capital(Or Share Stock) |
186,136,986.00 |
| Capital Surplus |
1,229,379,048.66 |
| Surplus Reserve |
79,683,304.25 |
| LESS:Treasury Stock |
1,907,924.48 |
| Undistributed Profits |
373,715,628.36 |
| Minority Stockholder's Interest |
-20,712,152.62 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,868,478,541.21 |
| Owner's Equity（Stockholder's Equity） |
1,847,766,388.59 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,272,406,582.03 |
